logo

Abbott Laboratories (ABT)



Trade ABT now with
  Date
  Headline
7/26/2018 9:02:16 AM Abbott Begins U.S. Pivotal Trial For Tendyne Mitral Valve Replacement System
7/24/2018 4:32:58 PM ViewRay Appoints Scott Drake As President, CEO And Director
7/18/2018 7:55:39 AM Abbott Laboratories (ABT) Has Raised Its FY18 EPS Estimate To 2.85 - 2.91 From 2.80 - 2.90
7/18/2018 7:48:52 AM Abbott Q2 Reported EPS From Cont Opns $0.40; Adj EPS From Cont. Opns $0.73
7/12/2018 9:01:38 AM Abbott Gets FDA Approval For Next-Generation MitraClip Device To Treat People With Leaky Heart Valves
6/8/2018 10:25:22 AM Abbott Laboratories (ABT) Declares Quarterly Dividend of $ 0.28, Record Date 7/13/2018
6/8/2018 10:18:54 AM Abbott Declares Quarterly Dividend Of $0.28/shr; Payable Aug. 15/ Record July 13
5/22/2018 6:24:40 AM Abbott Announces Five-year Results From FAME 2 Study
5/3/2018 9:02:54 AM Abbott Announces FDA Clearance Of Advisor HD Grid Mapping Catheter, Sensor Enabled
5/2/2018 9:05:14 AM Abbott: XIENCE Sierra Heart Stent Receives National Reimbursement In Japan For Coronary Artery Disease
4/20/2018 10:11:55 AM Abbott Extends Title Sponsorship Of Abbott World Marathon Majors Through 2023
4/19/2018 8:00:02 AM RBC Capital Markets Is Lowering Abbott Laboratories (ABT) 4Q18 Estimate To 0.84 From 0.86
4/19/2018 7:59:54 AM RBC Capital Markets Is Raising Abbott Laboratories (ABT) 3Q18 Estimate To 0.72 From 0.71
4/19/2018 7:59:42 AM RBC Capital Markets Is Raising Abbott Laboratories (ABT) 2Q18 Estimate To 0.71 From 0.69